Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Ichiro Hanamura · SciRah

Researcher profile · Semantic Scholar

Ichiro Hanamura

Share profile

Ichiro Hanamura — researcher profile on SciRah

h-index: 22
Works: 145
Citations: 4,912

Most-cited papers

Multiple myeloma with high-risk cytogenetics and its treatment approach
Ichiro Hanamura
2022International journal of hematology115 citations Open access
Semantic Scholar
Gain/Amplification of Chromosome Arm 1q21 in Multiple Myeloma
Ichiro Hanamura
2021Cancers85 citations Open access
Semantic Scholar
Importance of Glutamine Metabolism in Leukemia Cells by Energy Production Through TCA Cycle and by Redox Homeostasis
Mineaki Goto, H. Miwa, M. Shikami, Norikazu Tsunekawa-Imai +6 more
2014Cancer Investigation70 citations
Semantic Scholar
Adaptation of leukemia cells to hypoxic condition through switching the energy metabolism or avoiding the oxidative stress
Mineaki Goto, H. Miwa, Kazuto Suganuma, Norikazu Tsunekawa-Imai +5 more
2014BMC Cancer57 citations Open access
Semantic Scholar
EBV‐positive mucocutaneous ulcer arising in rheumatoid arthritis patients treated with methotrexate: Single center series of nine cases
A. Satou, S. Banno, Ichiro Hanamura, Emiko Takahashi +8 more
2019Pathology international (Print)51 citations
Semantic Scholar
Intrinsically disordered Meningioma-1 stabilizes the BAF complex to cause AML.
Simone S. Riedel, Congcong Lu, Hongbo M. Xie, Kevin Nestler +9 more
2021Molecules and Cells36 citations Open access
Semantic Scholar
Immunomodulatory and Metabolic Changes after Gnetin-C Supplementation in Humans
Y. Nakagami, Susumu Suzuki, J. L. Espinoza, Lam Vu Quang +7 more
2019Nutrients27 citations Open access
Semantic Scholar
Biallelic loss of FAM46C triggers tumor growth with concomitant activation of Akt signaling in multiple myeloma cells
Jo Kanasugi, Ichiro Hanamura, Akinobu Ota, S. Karnan +9 more
2020Cancer Science22 citations Open access
Semantic Scholar
Outcomes after R-CHOP in patients with newly diagnosed advanced follicular lymphoma: a 10-year follow-up analysis of the JCOG0203 trial.
Takashi Watanabe, K. Tobinai, M. Wakabayashi, Y. Morishima +100 more
2018The Lancet Haematology22 citations
Semantic Scholar
Novel combined Ato-C treatment synergistically suppresses proliferation of Bcr-Abl-positive leukemic cells in vitro and in vivo.
M. Wahiduzzaman, Akinobu Ota, S. Karnan, Ichiro Hanamura +8 more
2018Cancer Letters19 citations
Semantic Scholar
R‐High‐CHOP/CHASER/LEED with autologous stem cell transplantation in newly diagnosed mantle cell lymphoma: JCOG0406 STUDY
M. Ogura, Kazuhito Yamamoto, Y. Morishima, M. Wakabayashi +29 more
2018Cancer Science18 citations Open access
Semantic Scholar
A nationwide survey on central nervous system multiple myeloma in Japan: analysis of prognostic and treatment factors that impact survival
Takeshi Yamashita, H. Takamatsu, K. Kawamura, Kazutaka Sunami +19 more
2021British Journal of Haematology16 citations Open access
Semantic Scholar
Efficacy and safety of autologous stem cell transplantation in patients aged ≥ 65 years with multiple myeloma in the era of novel agents
Shohei Mizuno, Koji Kawamura, Ichiro Hanamura, Kazutaka Sunami +14 more
2019Bone Marrow Transplantation16 citations
Semantic Scholar
Establishment and characterization of CRISPR/Cas9‐mediated NF2 −/− human mesothelial cell line: Molecular insight into fibroblast growth factor receptor 2 in malignant pleural mesothelioma
M. Wahiduzzaman, S. Karnan, Akinobu Ota, Ichiro Hanamura +7 more
2018Cancer Science16 citations Open access
Semantic Scholar
CD52 is a novel target for the treatment of FLT3-ITD-mutated myeloid leukemia
S. Karnan, Ichiro Hanamura, Akinobu Ota, Souichi Takasugi +17 more
2021Cell Death Discovery13 citations Open access
Semantic Scholar
Expression of activated integrin β7 in multiple myeloma patients
N. Hosen, S. Yoshihara, H. Takamatsu, Masaki Ri +22 more
2021International journal of hematology13 citations
Semantic Scholar
ARK5 enhances cell survival associated with mitochondrial morphological dynamics from fusion to fission in human multiple myeloma cells
S. Karnan, Ichiro Hanamura, Akinobu Ota, L. Vu +15 more
2024Cell Death Discovery11 citations Open access
Semantic Scholar
Donor Heme Oxygenase-1 Promoter Gene Polymorphism Predicts Survival after Unrelated Bone Marrow Transplantation for High-Risk Patients
Tomohiro Horio, E. Morishita, Shohei Mizuno, Kaori Uchino +12 more
2020Cancers11 citations Open access
Semantic Scholar
Combining T‐cell‐based immunotherapy with venetoclax elicits synergistic cytotoxicity to B‐cell lines in vitro
Satsuki Murakami, Susumu Suzuki, Ichiro Hanamura, K. Yoshikawa +3 more
2020Hematological Oncology11 citations
Semantic Scholar
Identification of CD24 as a potential diagnostic and therapeutic target for malignant pleural mesothelioma
S. Karnan, Akinobu Ota, H. Murakami, Md. Lutfur Rahman +9 more
2020Cell Death Discovery11 citations Open access
Semantic Scholar
Synergistic Effects of Venetoclax and Daratumumab on Antibody-Dependent Cell-Mediated Natural Killer Cytotoxicity in Multiple Myeloma
Ayano Nakamura, Susumu Suzuki, Jo Kanasugi, Masayuki Ejiri +4 more
2021International Journal of Molecular Sciences10 citations Open access
Semantic Scholar
Randomised phase II study to optimise melphalan, prednisolone, and bortezomib in untreated multiple myeloma (JCOG1105)
D. Maruyama, S. Iida, G. Ogawa, N. Fukuhara +21 more
2020British Journal of Haematology10 citations Open access
Semantic Scholar
Novel Interleukin-6 Inducible Gene PDZ-Binding Kinase Promotes Tumor Growth of Multiple Myeloma Cells
Akinobu Ota, Ichiro Hanamura, S. Karnan, Shingo Inaguma +12 more
2020Journal of Interferon and Cytokine Research10 citations Open access
Semantic Scholar
Pretreatment Immature Platelet Fraction as a Surrogate of Reticulated Platelets Predicts the Response to Corticosteroids in Adults with Immune Thrombocytopenia
A. Takami, Shohei Mizuno, Ayano Nakamura, Jo Kanasugi +15 more
2020Acta Haematologica10 citations
Semantic Scholar
Primary cutaneous methotrexate-associated B-cell lymphoproliferative disorders other than EBV-positive mucocutaneous ulcer: clinical, pathological, and immunophenotypic features.
A. Satou, S. Banno, K. Kohno, Taishi Takahara +9 more
2021Pathology (Sydney)9 citations
Semantic Scholar
Bortezomib plus dexamethasone vs thalidomide plus dexamethasone for relapsed or refractory multiple myeloma
S. Iida, M. Wakabayashi, K. Tsukasaki, K. Miyamoto +16 more
2018Cancer Science9 citations Open access
Semantic Scholar
Toll-like receptor genetic variations in bone marrow transplantation
Kaori Uchino, Shohei Mizuno, A. Sato-Otsubo, Y. Nannya +14 more
2017OncoTarget9 citations Open access
Semantic Scholar
Cytotoxicity of Callerya speciosa Fractions against Myeloma and Lymphoma Cell Lines
Vu Quang Lam, La Hoang Anh, Quan Van Nguyen, X. Tran +4 more
2022Molecules8 citations Open access
Semantic Scholar
Cytopenia associated with copper deficiency
Kaori Uchino, L. Quang, Megumi Enomoto, Yuta Nakano +13 more
2021eJHaem8 citations Open access
Semantic Scholar
Consensus Guidelines and Recommendations for The CD38 Monoclonal Antibody-based Quadruplet Therapy and Management in Clinical Practice for Newly Diagnosed Multiple Myeloma: From the Pan-Pacific Multiple Myeloma Working Group
Wen-Ming Chen, Zhen Cai, J. Chim, W. Chng +11 more
2025Clinical Hematology International7 citations
Semantic Scholar
Potential role of Howell−Jolly bodies in identifying functional hyposplenism: a prospective single-institute study
Y. Nakagami, Kaori Uchino, H. Okada, Kojiro Suzuki +7 more
2020International journal of hematology7 citations
Semantic Scholar
Primary Plasma Cell Leukemia: Recent Advances in Molecular Understanding and Treatment Approaches
Ichiro Hanamura, S. Karnan, Akinobu Ota, Akiyoshi Takami
2025International Journal of Molecular Sciences6 citations
Semantic Scholar
CAMK2D: a novel molecular target for BAP1-deficient malignant mesothelioma
S. Karnan, Akinobu Ota, H. Murakami, Md. Lutfur Rahman +12 more
2023Cell Death Discovery6 citations Open access
Semantic Scholar
Establishment and characterization of a novel vincristine‐resistant diffuse large B‐cell lymphoma cell line containing the 8q24 homogeneously staining region
Shohei Mizuno, Ichiro Hanamura, Akinobu Ota, S. Karnan +17 more
2018FEBS Open Bio6 citations Open access
Semantic Scholar
The recipient CCR5 variation predicts survival outcomes after bone marrow transplantation.
Tomohiro Horio, Shohei Mizuno, Kaori Uchino, Motonori Mizutani +11 more
2017Transplant Immunology6 citations
Semantic Scholar
Overexpression of salivary-type amylase reduces the sensitivity to bortezomib in multiple myeloma cells
Shohei Mizuno, Ichiro Hanamura, Akinobu Ota, S. Karnan +13 more
2015International journal of hematology6 citations
Semantic Scholar
Consensus Guidelines and Recommendations for the anti-CD38-based Therapy in Clinical Practice for Relapsed/Refractory Multiple Myeloma: From the Pan-Pacific Multiple Myeloma Working Group
Wen-Ming Chen, Zhen Cai, C. S. Chim, W. Chng +13 more
2025Clinical Hematology International5 citations
Semantic Scholar
Clinical practice guidelines for molecular tumor marker, 2nd edition review part 2
Yoshinori Kikuchi, Hideaki Shimada, F. Yamasaki, Taku Yamashita +21 more
2024International Journal of Clinical Oncology5 citations
Semantic Scholar
Donor UNC-93 Homolog B1 genetic polymorphism predicts survival outcomes after unrelated bone marrow transplantation
Kaori Uchino, Lam Vu Quang, Shohei Mizuno, Tomohiro Horio +14 more
2021Genes and Immunity5 citations Open access
Semantic Scholar
Toll-like receptor 1 variation increases the risk of transplant-related mortality in hematologic malignancies.
Kaori Uchino, Shohei Mizuno, Motonori Mizutani, Tomohiro Horio +12 more
2016Transplant Immunology5 citations
Semantic Scholar
Primary Bladder Lymphoma with Extravesical Extension: A Case Report and Literature Review on Prognosis and Clinical Characteristics
Hideshige Seki, Shohei Mizuno, Sakura Saigusa, Yukie Sugita +6 more
2024Journal of Clinical Medicine4 citations Open access
Semantic Scholar
Plasma cell myeloma positive for t(14;20) with relapse in the central nervous system
T. Murase, A. Inagaki, Ayako Masaki, Keiichiro Fujii +5 more
2019Journal of Clinical and Experimental Hematopathology4 citations Open access
Semantic Scholar
Reduced frequency treatment with bortezomib plus dexamethasone for elderly patients with relapsed and/or refractory multiple myeloma: a phase 2 study of the Japanese Myeloma Study Group (JMSG-0902)
S. Ozaki, H. Hata, M. Abe, T. Saitoh +11 more
2016Annals of Hematology4 citations
Semantic Scholar
Targeting fatty acid synthase suppresses tumor development in NF2/CDKN2A-deficient malignant pleural mesothelioma
S. Karnan, Akinobu Ota, M. N. Hasan, Hideki Murakami +15 more
2024bioRxiv3 citations Open access
Semantic Scholar
Final analysis of randomized phase II study optimizing melphalan, prednisolone, bortezomib in multiple myeloma (JCOG1105)
D. Maruyama, S. Iida, R. Machida, S. Kusumoto +24 more
2022Cancer Science3 citations Open access
Semantic Scholar
Chromosomal translocation t(11;14) and p53 deletion induced by the CRISPR/Cas9 system in normal B cell-derived iPS cells
Yusuke Azami, N. Tsuyama, Y. Abe, Misaki Sugai-Takahashi +13 more
2021Scientific Reports3 citations Open access
Semantic Scholar
The Clinical and Biological Effects of PD-1 Expression on Tumor Cells in Diffuse Large B-Cell Lymphoma
Ichiro Hanamura, Susumu Suzuki, Akinobu Ota, Satsuki Murakami +13 more
2021Hemato3 citations Open access
Semantic Scholar
Targeting fatty acid synthase suppresses tumor development in NF2/CDKN2A-deficient pleural mesothelioma
S. Karnan, Akinobu Ota, M. N. Hasan, Hideki Murakami +15 more
2026Cell Death and Disease2 citations Open access
Semantic Scholar
Underrecognised Functional Hyposplenism Associated With Chronic Graft‐Versus‐Host Disease: A Case Report
Kaori Uchino, Y. Nakagami, Megumi Enotomoto, Nozomi Shimizu +14 more
2025eJHaem2 citations Open access
Semantic Scholar
Changing trends in the risk factors for second primary malignancies after autologous stem cell transplantation for multiple myeloma before and after the introduction of proteasome inhibitors and immunomodulatory drugs
H. Takamatsu, T. Matsuda, Shohei Mizuno, Tsutomu Takahashi +19 more
2023Haematologica2 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Takami×22
Invite
A. Takami — researcher profile on SciRah
Shohei Mizuno×20
Invite
Shohei Mizuno — researcher profile on SciRah
S. Karnan×15
Invite
S. Karnan — researcher profile on SciRah
Kaori Uchino×14
Invite
Kaori Uchino — researcher profile on SciRah

×12

Invite

Y. Hosokawa — researcher profile on SciRah

Tomohiro Horio×11

Invite

Tomohiro Horio — researcher profile on SciRah

M. Wahiduzzaman×10

Invite

M. Wahiduzzaman — researcher profile on SciRah

Md. Lutfur Rahman×10

Invite

Md. Lutfur Rahman — researcher profile on SciRah

Toshinori Hyodo×10

Invite

Toshinori Hyodo — researcher profile on SciRah

Invite

H. Konishi — researcher profile on SciRah

Invite

S. Iida — researcher profile on SciRah

Invite

Akinobu Ota — researcher profile on SciRah